Foscarnet is an antiviral medicine used to treat certain types of eye infections caused by the herpes virus. It can also be used for other viral infections.
Every report comes from a Lived member, sent anonymously.
Have you tried Foscarnet for CMV Retinitis?
Foscarnet, sold under the brand name Foscavir and also available as a generic, is an antiviral medicine given through a vein. It is reserved for serious herpes-family virus infections in people whose immune systems are weakened, usually when standard treatments are unsuitable or have stopped working. It has two FDA-approved uses. The first is cytomegalovirus (CMV) retinitis in people with AIDS. CMV is a common virus that usually stays dormant, but in someone with a severely weakened immune system it can infect the retina, the light-sensing layer at the back of the eye, and threaten vision. Foscarnet can be used on its own, or together with ganciclovir (another CMV antiviral) when retinitis has come back after treatment with either drug alone. The second is herpes simplex virus (HSV) infection of the skin or mucous membranes, such as the mouth or the genital and anal area, in people with weakened immunity when the virus no longer responds to acyclovir, the usual herpes medicine. Transplant specialists also use foscarnet, outside its formal approval, for CMV infection after an organ transplant that is resistant to ganciclovir or not improving on it, particularly when the infection involves the eye or brain or the amount of virus in the blood is high. Its benefit has not been established for other CMV or HSV infections, for newborns, or for people whose immune systems work normally.
Herpes-family viruses, including CMV and HSV, copy their genetic material with their own enzyme, called DNA polymerase. Foscarnet blocks this viral enzyme directly, at levels that leave the body's own DNA-copying enzymes largely untouched, so the virus cannot multiply. That slows the infection and gives the immune system and other care a chance to control it; it does not clear virus that is already present. Acyclovir and ganciclovir only work after an enzyme inside the infected cell activates them, and changes in that activating enzyme are one way viruses become resistant to them. Foscarnet needs no activation step, which is why it can still work against many strains that resist those drugs. Viruses can also become resistant to foscarnet, through changes in the polymerase itself, so it is not a guaranteed backup.
Foscarnet is given only as an intravenous (IV) infusion, never as a pill or a quick injection. Each dose runs slowly, over one to two hours, through a programmed infusion pump, because a dose delivered too fast sends blood levels sharply higher and raises the risk of serious side effects. It is infused into a vein with good blood flow to limit irritation. Treatment begins with an induction phase: infusions every 8 or 12 hours, for about two to three weeks for CMV retinitis, or for HSV until the sores heal. For CMV retinitis, induction is followed by a once-daily maintenance infusion to keep the infection in check. Doses are calculated from body weight and kidney function and recalculated as kidney test results change, even when they still look normal. To protect the kidneys, IV fluids (salt water or a sugar solution) are given before the first dose and alongside every infusion after that. Treatment often starts in the hospital; some people continue infusions at home after training from a home infusion team.
Fever, nausea, vomiting, diarrhea, headache and tiredness are common during treatment, as is pain or irritation where the IV enters the vein. Some people develop irritation or sores on the penis or around the vagina, probably because the drug leaves the body in urine; staying well hydrated and careful hygiene can help. Anemia (low red blood cells) and low white blood cell counts are also common and are watched on blood tests. Kidney damage is the main serious risk and the reason for the medicine's boxed warning, the FDA's most prominent caution. It most often shows up in the second week of treatment but can appear at any time, and it usually improves after the dose is lowered or the drug is stopped, though not always. Routine blood tests usually catch it first. Passing much less urine than usual, new swelling in the legs or ankles, or unusual tiredness or weakness should be reported to the care team right away. Foscarnet also binds calcium and magnesium in the blood and can shift potassium and phosphate levels. Active (ionized) calcium can drop during an infusion even when a standard calcium test looks normal. Tingling around the mouth, numbness or tingling in the fingers or toes, and muscle spasms are early signs: tell the nurse or care team at once, since the infusion is usually stopped until blood levels are checked. These mineral shifts can trigger seizures, which occurred in about 1 in 10 people with AIDS in the early studies. A seizure, swelling of the face, lips, tongue or throat, or trouble breathing needs emergency care: call 911. A racing, pounding or irregular heartbeat, or fainting, also needs emergency evaluation, because foscarnet can disturb the heart's rhythm.
The biggest interaction concern is combining foscarnet with other medicines that strain the kidneys. These include aminoglycoside antibiotics (such as tobramycin or amikacin), amphotericin B (an antifungal), the anti-rejection drugs cyclosporine and tacrolimus, methotrexate, and acyclovir. Intravenous pentamidine, a treatment for a type of pneumonia, is a particular danger because it also lowers calcium; one patient given both died of severely low calcium. These combinations are avoided unless the benefit clearly outweighs the risk. Foscarnet can lengthen the QT interval, a measure on an electrocardiogram (ECG) of how long the heart takes to reset between beats. A long QT interval can lead to a dangerous irregular rhythm. Care teams check an ECG and electrolytes before and during treatment and try to avoid other medicines that lengthen QT, such as certain heart rhythm drugs (amiodarone or sotalol, for example), some macrolide and fluoroquinolone antibiotics, tricyclic antidepressants, and phenothiazines, a group of antipsychotic and anti-nausea medicines. Each dose carries a substantial load of sodium and fluid, so foscarnet is generally avoided in people with weakened heart muscle (cardiomyopathy) or on a sodium-restricted diet. The only absolute reason not to use it is a previous serious allergic reaction to foscarnet; kidney disease is not a bar to treatment, but it calls for lower or less frequent doses. Foscarnet has not been well studied in pregnancy and is used then only when clearly needed. In animal studies it passed into breast milk, so breastfeeding during treatment needs a decision with the care team. Its safety in children has not been established; it collects in bone and teeth, which may matter more while they are still growing. Dizziness or seizures can make driving unsafe during treatment.
Foscarnet treatment is demanding. Kidney function and calcium, magnesium, potassium and phosphate levels are usually checked two or three times a week during induction and about weekly during maintenance, along with blood counts and periodic ECGs. Based on the results, doses are adjusted, minerals are replaced, or treatment is paused. Between the infusion and the fluids given with it, each dose takes up several hours of the day. Foscarnet controls these infections but does not cure them. For CMV retinitis, the aim is to stop the retinitis from spreading and protect remaining vision. It can still progress during or after treatment, so regular exams with an eye specialist are part of care. If it progresses during maintenance, induction can be repeated, or foscarnet can be combined with ganciclovir. With acyclovir-resistant herpes, sores can heal completely, but most people have a relapse later. A relapse may respond to acyclovir again, and repeated foscarnet courses can lead to resistance, so a sample of the virus is often tested to guide the next choice. After a transplant, foscarnet is often used to bring a resistant CMV infection under control. Once the amount of virus in the blood has fallen, specialists may switch to maribavir, an oral CMV antiviral with fewer side effects. Kidney changes usually improve after foscarnet is reduced or stopped, but not in every case.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Foscarnet, what you've noticed, or ask the community a question.